Growth Metrics

Opus Genetics (IRD) Non-cash Items (2011 - 2020)

Opus Genetics (IRD) reported Non-cash Items of $102939.0 for Q3 2020, down 15.73% year-over-year from $122150.0 in Q4 2019, and up 4.15% on a QoQ basis from $98834.0 in Q2 2020.

Opus Genetics (IRD) has 10 years of Non-cash Items data on file, last reported at $102939.0 in Q3 2020.

  • Quarterly Non-cash Items fell 15.73% year-over-year to $102939.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $102939.0 (down 15.73% YoY) and the FY2019 annual result came in at $123263.0, down 91.75% from the prior year.
  • Non-cash Items advanced to $102939.0 in Q3 2020 per IRD's latest filing, from $98834.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $8.5 million in Q3 2016 and bottomed at $50870.0 in Q3 2018.
  • The 5-year median for Non-cash Items is $342455.0 (2017), against an average of $2.2 million.
  • The widest annual swing landed in 2016, when Non-cash Items soared 29821.43%; it then slumped 99.32% in 2017.
  • Tracing IRD's Non-cash Items over 5 years: stood at $7.9 million in 2016, then tumbled by 99.32% to $53883.0 in 2017, then jumped by 2671.5% to $1.5 million in 2018, then sank by 91.75% to $123263.0 in 2019, then fell by 16.49% to $102939.0 in 2020.
  • Per Business Quant, the three latest IRD Non-cash Items figures stand at $102939.0 (Q3 2020), $98834.0 (Q2 2020), and $75304.0 (Q1 2020).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Opus Genetics 357.99 Mn 298.03 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2020 102,939.00
Sep 30, 2020 102,939.00
Jun 30, 2020 98,834.00
Jun 30, 2020 98,834.00
Mar 31, 2020 75,304.00
Mar 31, 2020 75,304.00
Dec 31, 2019 123,263.00
Dec 31, 2019 123,263.00
Sep 30, 2019 122,150.00
Sep 30, 2019 122,150.00
Jun 30, 2019 119,953.00
Jun 30, 2019 119,953.00
Mar 31, 2019 138,292.00
Mar 31, 2019 138,292.00
Dec 31, 2018 1.49 Mn
Dec 31, 2018 1.49 Mn
Sep 30, 2018 50,870.00
Sep 30, 2018 50,870.00
Jun 30, 2018 1.32 Mn
Jun 30, 2018 1.32 Mn
Mar 31, 2018 1.23 Mn
Mar 31, 2018 1.23 Mn
Dec 31, 2017 53,883.00
Dec 31, 2017 53,883.00
Sep 30, 2017 1.07 Mn
Sep 30, 2017 1.07 Mn
Jun 30, 2017 342,455.00
Jun 30, 2017 342,455.00
Mar 31, 2017 2.36 Mn
Mar 31, 2017 2.36 Mn
Dec 31, 2016 7.93 Mn
Dec 31, 2016 7.93 Mn
Sep 30, 2016 8.53 Mn
Sep 30, 2016 8.53 Mn
Jun 30, 2016 8.12 Mn
Jun 30, 2016 8.12 Mn
Mar 31, 2016 8.04 Mn
Mar 31, 2016 8.04 Mn
Dec 31, 2015 26,500.00
Dec 31, 2015 26,500.00
Sep 30, 2015 360,000.00
Sep 30, 2015 360,000.00
Jun 30, 2015 597,200.00
Jun 30, 2015 597,200.00
Mar 31, 2015 991,726.00
Mar 31, 2015 991,726.00
Dec 31, 2014 842,300.00
Dec 31, 2014 842,300.00
Sep 30, 2014 1.20 Mn
Sep 30, 2014 1.20 Mn
Jun 30, 2014 1.49 Mn
Jun 30, 2014 1.49 Mn
Mar 31, 2014 2.86 Mn
Mar 31, 2014 2.86 Mn
Dec 31, 2013 350,865.00
Dec 31, 2013 350,865.00
Sep 30, 2013 209,717.00
Sep 30, 2013 209,717.00
Jun 30, 2013 8.74 Mn
Jun 30, 2013 8.74 Mn
Mar 31, 2013 8.57 Mn
Mar 31, 2013 8.57 Mn
Dec 31, 2012 41,706.00
Dec 31, 2012 41,706.00
Sep 30, 2012 191,915.00
Sep 30, 2012 191,915.00
Jun 30, 2012 47,664.00
Jun 30, 2012 47,664.00
Dec 31, 2011 6.91 Mn
Dec 31, 2011 6.91 Mn